Host-targeted Nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir

Publication date: Available online 13 June 2020Source: Antiviral ResearchAuthor(s): Danielle Tilmanis, Paulina Koszalka, Ian G. Barr, Jean-Francois Rossignol, Edin Mifsud, Aeron C. Hurt
Source: Antiviral Therapy - Category: Virology Source Type: research